FDA Releases Draft Guidance for Labeling of OTC Topical Drug Products for Vaginal Yeast Infections

Summary

The FDA has made available a draft guidance for industry outlining recommended labeling formats for over-the-counter topical drug products treating vaginal yeast infections, aiming to standardize carton and educational brochure content.